Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/3/2025

Blood Pressure Management in Intracerebral Hemorrhage

Key Findings and Recommendations

  • The American Heart Association recommends targeting a systolic blood pressure range of 130-140 mmHg in patients with mild to moderate intracerebral hemorrhage, as this is safe and may improve functional outcomes, with a strength of evidence based on the ATACH-2 trial 1, 2
  • For patients with very high baseline systolic blood pressure (≥220 mmHg), more cautious blood pressure lowering is required, as post hoc analysis of ATACH-2 showed higher rates of neurological deterioration and renal adverse events without benefit in reducing hematoma expansion or improving outcomes 3

Medication Selection and Monitoring

  • The American College of Cardiology recommends using IV nicardipine, starting at 5 mg/hour with titration to achieve target, as a first-line agent for blood pressure management in intracerebral hemorrhage, with labetalol as an alternative 5
  • Avoid using venous vasodilators (e.g., nitroprusside) due to potential negative effects on hemostasis and intracranial pressure 5, 6

Special Populations and Timing Considerations

  • For patients with moderate to severe intracerebral hemorrhage, maintain cerebral perfusion pressure (CPP) 60-70 mmHg during blood pressure reduction, with frequent monitoring to avoid large fluctuations 5, 6
  • Treatment within 2 hours of onset is associated with lower hematoma expansion risk and improved 90-day outcomes, with a mean time to treatment initiation of 182±57 minutes in the ATACH-2 trial 2, 5